Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Sheel Biotech Ltd

SHEEL
NSE
46.65
0.53%
Last Updated:
30 Apr '26, 4:00 PM
Alert
Watchlist
Note

Sheel Biotech Ltd

SHEEL
NSE
46.65
0.53%
30 Apr '26, 4:00 PM
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
95Cr
Close
Close Price
46.65
Industry
Industry
Floriculture/Tissue Culture
PE
Price To Earnings
PS
Price To Sales
0.85
Revenue
Revenue
112Cr
Rev Gr TTM
Revenue Growth TTM
PAT Gr TTM
PAT Growth TTM
Peer Comparison
How does SHEEL stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
SHEEL
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2024Mar 2025Sep 2025
Revenue
RevenueCr
119022
Growth YoY
Revenue Growth YoY%
93.7
Expenses
ExpensesCr
147320
Operating Profit
Operating ProfitCr
-2172
OPM
OPM%
-21.919.38.1
Other Income
Other IncomeCr
000
Interest Expense
Interest ExpenseCr
111
Depreciation
DepreciationCr
001
PBT
PBTCr
-3171
Tax
TaxCr
020
PAT
PATCr
-4150
Growth YoY
PAT Growth YoY%
105.0
NPM
NPM%
-33.516.10.9
EPS
EPS
0.00.00.0

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
63718092102112
Growth
Revenue Growth%
12.213.315.210.310.4
Expenses
ExpensesCr
576471788793
Operating Profit
Operating ProfitCr
769141519
OPM
OPM%
10.39.011.015.714.717.1
Other Income
Other IncomeCr
000011
Interest Expense
Interest ExpenseCr
112122
Depreciation
DepreciationCr
111111
PBT
PBTCr
556121318
Tax
TaxCr
001222
PAT
PATCr
555101115
Growth
PAT Growth%
-6.012.6106.31.538.5
NPM
NPM%
7.66.46.311.310.413.1
EPS
EPS
11.63.13.57.27.20.0

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital
Equity CapitalCr
444415
Reserves
ReservesCr
5356596969
Current Liabilities
Current LiabilitiesCr
1320212324
Non Current Liabilities
Non Current LiabilitiesCr
121410115
Total Liabilities
Total LiabilitiesCr
829394106113
Current Assets
Current AssetsCr
74838395101
Non Current Assets
Non Current AssetsCr
810111112
Total Assets
Total AssetsCr
829394106113

Cash Flow

Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
29-19
Investing Cash Flow
Investing Cash FlowCr
-2-20-2
Financing Cash Flow
Financing Cash FlowCr
0-72-7
Net Cash Flow
Net Cash FlowCr
0000
Free Cash Flow
Free Cash FlowCr
18-18
CFO To PAT
CFO To PAT%
48.6183.0-8.886.6
CFO To EBITDA
CFO To EBITDA%
34.3105.3-6.461.5

Ratios

Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
00000
Price To Earnings
Price To Earnings
0.00.00.00.00.0
Price To Sales
Price To Sales
0.00.00.00.00.0
Price To Book
Price To Book
0.00.00.00.00.0
EV To EBITDA
EV To EBITDA
3.13.62.11.61.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
33.549.250.450.748.1
OPM
OPM%
10.39.011.015.714.7
NPM
NPM%
7.66.46.311.310.4
ROCE
ROCE%
7.76.99.514.314.4
ROE
ROE%
8.57.58.014.412.7
ROA
ROA%
5.84.85.49.99.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios